{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:37:08Z","timestamp":1791290228400,"version":"4.3.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.pharmthera.2007.08.001","type":"journal-article","created":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T11:12:04Z","timestamp":1188385924000},"page":"428-436","source":"Crossref","is-referenced-by-count":63,"title":["l-Arginine transporters in cardiovascular disease: A novel therapeutic target"],"prefix":"10.1016","volume":"116","author":[{"given":"J.P.F.","family":"Chin-Dusting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0735-1097(98)00206-X","article-title":"Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis","volume":"32","author":"Adams","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00004872-200402000-00016","article-title":"An age-related decline in endothelial function is not associated with alterations in l-arginine transport in humans","volume":"22","author":"Ahlers","year":"2004","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.CIR.95.2.430","article-title":"l-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice","volume":"95","author":"Aji","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib6","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1172\/JCI117957","article-title":"Interactions between l-arginine and l-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability","volume":"95","author":"Arnal","year":"1995","journal-title":"J Clin Invest"},{"issue":"8-9","key":"10.1016\/j.pharmthera.2007.08.001_bib5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s000180050358","article-title":"Endothelium-derived nitric oxide and vascular physiology and pathology","volume":"55","author":"Arnal","year":"1999","journal-title":"Cell Mol Life Sci"},{"issue":"43","key":"10.1016\/j.pharmthera.2007.08.001_bib7","doi-asserted-by":"crossref","first-page":"30424","DOI":"10.1074\/jbc.274.43.30424","article-title":"Post-transcriptional regulation of the arginine transporter Cat-1 by amino acid availability","volume":"274","author":"Aulak","year":"1999","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib8","first-page":"331","article-title":"Arginine enhances wound healing and lymphocyte immune responses in humans","volume":"108","author":"Barbul","year":"1990","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/bbrc.1994.1511","article-title":"Selective targeting of nitric oxide synthase inhibitors to system y+in activated macrophages","volume":"200","author":"Baydoun","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2007.08.001_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/0264-6021:3440265","article-title":"Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells","volume":"344","author":"Baydoun","year":"1999","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib12","first-page":"14","article-title":"l-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor","volume":"10","author":"Boger","year":"2005","journal-title":"Altern Med Rev"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.08.001_bib11","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.95.8.2068","article-title":"Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease","volume":"95","author":"Boger","year":"1997","journal-title":"Circulation"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2007.08.001_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj2840015","article-title":"l-Arginine transport is increased in macrophages generating nitric oxide","volume":"284","author":"Bogle","year":"1992","journal-title":"Biochem J"},{"issue":"10","key":"10.1016\/j.pharmthera.2007.08.001_bib14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular disease: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.ATV.16.1.44","article-title":"Regression or progression. Dependency on vascular nitric oxide","volume":"16","author":"Candipan","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.pharmthera.2007.08.001_bib16","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1073\/pnas.90.16.7749","article-title":"Plasma Arginine and Citrulline kinetics in adults given in adequate and arginine free-diets","volume":"90","author":"Casttillo","year":"1993","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"10.1016\/j.pharmthera.2007.08.001_bib17","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.93.21.11460","article-title":"Whole body nitric oxide synthesis in healthy men determined from [15N] arginine to [15N] citrulline labelling","volume":"93","author":"Castillo","year":"1996","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.08.001_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9149(97)00354-8","article-title":"Effect of supplemental oral l-arginine on exercise capacity in patients with stable angina pectoris","volume":"80","author":"Ceremuzynski","year":"1997","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00005344-199607000-00023","article-title":"Effects of in vivo and in vitro l-arginine supplementation on healthy human vessels","volume":"28","author":"Chin-Dusting","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.08.001_bib21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0735-1097(95)00611-7","article-title":"Dietary supplementation with l-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure","volume":"27","author":"Chin-Dusting","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.HYP.0000070024.59313.AE","article-title":"l-Arginine transport in humans with cortisol-induced hypertension","volume":"41","author":"Chin-Dusting","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01872207","article-title":"On the strategy of kinetic discrimination of amino acid transport systems","volume":"84","author":"Christensen","year":"1985","journal-title":"J Membr Biol"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0021-9258(18)91787-4","article-title":"Cationic amino acid transport in the rabbit reticulocyte. Na+-dependent inhibition of Na+-independent transport","volume":"244","author":"Christensen","year":"1969","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.08.001_bib24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1172\/JCI118632","article-title":"Oral l-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults","volume":"97","author":"Clarkson","year":"1996","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.pharmthera.2007.08.001_bib25","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1016\/S0021-9258(18)53209-9","article-title":"Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver","volume":"268","author":"Closs","year":"1993","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hCAT-2B","volume":"1","author":"Closs","year":"1997","journal-title":"Nitric Oxide"},{"issue":"21","key":"10.1016\/j.pharmthera.2007.08.001_bib27","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1021\/bi962829p","article-title":"Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties","volume":"36","author":"Closs","year":"1997","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0026-895X(24)26443-9","article-title":"Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters","volume":"57","author":"Closs","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"10 Suppl","key":"10.1016\/j.pharmthera.2007.08.001_bib29","doi-asserted-by":"crossref","first-page":"2752S","DOI":"10.1093\/jn\/134.10.2752S","article-title":"Plasma membrane transporters for arginine","volume":"134","author":"Closs","year":"2004","journal-title":"J Nutr"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(03)00713-X","article-title":"A nutrient sensor mechanism controls drosophila growth","volume":"114","author":"Colombani","year":"2003","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.08.001_bib31","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.ATV.20.9.2032","article-title":"Does ADMA cause endothelial dysfunction?","volume":"20","author":"Cooke","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.08.001_bib32","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI115481","article-title":"Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator","volume":"88","author":"Cooke","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.08.001_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI115937","article-title":"Antiatherogenic effects of l-arginine in the hypercholesterolemic rabbit","volume":"90","author":"Cooke","year":"1992","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.08.001_bib34","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1172\/JCI115987","article-title":"l-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans","volume":"90","author":"Creager","year":"1992","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib35","first-page":"14","article-title":"l-Arginine and cardiovascular system","volume":"57","author":"Cylwik","year":"2005","journal-title":"Pharmacol Rep"},{"issue":"23 Suppl 1","key":"10.1016\/j.pharmthera.2007.08.001_bib36","first-page":"III27","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines","volume":"96","author":"De Caterina","year":"1995","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib38","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1161\/01.CIR.85.6.2284","article-title":"Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions","volume":"85","author":"de Graaf","year":"1992","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/physrev.1998.78.2.487","article-title":"Transporters for cationic amino acids in animal cells: discovery, structure, and function","volume":"78","author":"Deves","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1113\/jphysiol.1992.sp019275","article-title":"Identification of a new transport system (y+L) in human erythrocytes that recognizes lysine and leucine with high affinity","volume":"454","author":"Deves","year":"1992","journal-title":"J Physiol"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jn\/82.1.67","article-title":"A determination of the essential amino acid proportions needed to allow rapid growth in chicks","volume":"82","author":"Dobson","year":"1964","journal-title":"J Nutr"},{"issue":"8782-8783","key":"10.1016\/j.pharmthera.2007.08.001_bib42","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0140-6736(91)92372-9","article-title":"Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by l-arginine","volume":"338","author":"Drexler","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/CBB:35:1:19","article-title":"Regulation of l-arginine transport and metabolism in vascular smooth muscle cells","volume":"35","author":"Durante","year":"2001","journal-title":"Cell Biochem Biophys"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.08.001_bib44","first-page":"356","article-title":"Selective induction of a cationic amino acid transporter by tumor necrosis factor-alpha in vascular endothelium","volume":"108","author":"Durante","year":"1996","journal-title":"Proc. Assoc. Am. Physicians"},{"issue":"2 Pt 1","key":"10.1016\/j.pharmthera.2007.08.001_bib45","first-page":"L194","article-title":"l-Arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats","volume":"263","author":"Eddahibi","year":"1992","journal-title":"Am J Physiol"},{"issue":"15","key":"10.1016\/j.pharmthera.2007.08.001_bib47","doi-asserted-by":"crossref","first-page":"12285","DOI":"10.1074\/jbc.M009714200","article-title":"Internal ribosome entry site-mediated translation of a mammalian mRNA is regulated by amino acid availability","volume":"276","author":"Fernandez","year":"2001","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.pharmthera.2007.08.001_bib46","doi-asserted-by":"crossref","first-page":"11780","DOI":"10.1074\/jbc.M110778200","article-title":"Translation mediated by the internal ribosome entry site of the cat-1\u00a0mRNA is regulated by glucose availability in a PERK kinase-dependent manner","volume":"277","author":"Fernandez","year":"2002","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.pharmthera.2007.08.001_bib48","doi-asserted-by":"crossref","first-page":"19198","DOI":"10.1074\/jbc.M201052200","article-title":"Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2alpha","volume":"277","author":"Fernandez","year":"2002","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.pharmthera.2007.08.001_bib49","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"issue":"2-3","key":"10.1016\/j.pharmthera.2007.08.001_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(93)90275-M","article-title":"Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells","volume":"237","author":"Garg","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.08.001_bib52","first-page":"512","article-title":"Endothelial dysfunction and oxidative stress in chronic renal failure","volume":"17","author":"Ghiadoni","year":"2004","journal-title":"J Nephrol"},{"issue":"19","key":"10.1016\/j.pharmthera.2007.08.001_bib53","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1074\/jbc.271.19.11280","article-title":"Interleukin-1 beta and tumor necrosis factor-alpha stimulate the cat-2 gene of the l-arginine transporter in cultured vascular smooth muscle cells","volume":"271","author":"Gill","year":"1996","journal-title":"J Biol Chem"},{"issue":"10 Suppl","key":"10.1016\/j.pharmthera.2007.08.001_bib54","doi-asserted-by":"crossref","first-page":"2880S","DOI":"10.1093\/jn\/134.10.2880S","article-title":"Arginine and endothelial and vascular health","volume":"134","author":"Gornik","year":"2004","journal-title":"J Nutr"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib55","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/sj.bjp.0703921","article-title":"The transport activity of the human cationic amino acid transporter hCAT-1 is down regulated by activation of protein kinase C","volume":"132","author":"Graf","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"16","key":"10.1016\/j.pharmthera.2007.08.001_bib56","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1161\/01.CIR.0000093660.86242.BB","article-title":"Oxidative stress and cardiovascular injury: Part I. Basic mechanisms and in vivo monitoring of ROS","volume":"108","author":"Griendling","year":"2003","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.pharmthera.2007.08.001_bib57","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/01.CIR.0000093661.90582.c4","article-title":"Oxidative stress and cardiovascular injury: Part II. animals and human studies","volume":"108","author":"Griendling","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.08.001_bib58","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1172\/JCI119751","article-title":"Cellular and molecular mechanisms of endothelial cell dysfunction","volume":"100","author":"Harrison","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.nutr.23.011702.073120","article-title":"Regulation of cationic amino acids transport: the story of the CAT-1 transporter","volume":"24","author":"Hatzoglou","year":"2004","journal-title":"Annu Rev Nutr"},{"issue":"5512","key":"10.1016\/j.pharmthera.2007.08.001_bib61","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1126\/science.291.5512.2364","article-title":"Intracellular functions of N-linked glycans","volume":"291","author":"Helenius","year":"2001","journal-title":"Science"},{"issue":"4 pt 2","key":"10.1016\/j.pharmthera.2007.08.001_bib62","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.HYP.25.4.898","article-title":"Effects of l-arginine infusion on renal hemodynamics in patients with mild essential hypertension","volume":"25","author":"Higashi","year":"1995","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib64","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.CIR.90.2.658","article-title":"Effects of l-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure","volume":"90","author":"Hirooka","year":"1994","journal-title":"Circulation"},{"issue":"Suppl 12","key":"10.1016\/j.pharmthera.2007.08.001_bib65","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1097\/00005344-199204002-00055","article-title":"l-Arginine as an antihypertensive agent","volume":"20","author":"Hishikawa","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1536\/ihj.33.41","article-title":"Effect of systemic l-arginine administration on hemodynamics and nitric oxide release in man","volume":"33","author":"Hishikawa","year":"1992","journal-title":"Jpn Heart J"},{"issue":"13","key":"10.1016\/j.pharmthera.2007.08.001_bib67","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1074\/jbc.272.13.8717","article-title":"Cloning and characterization of a brain-specific cationic amino acid transporter","volume":"272","author":"Hosokawa","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1242\/jeb.196.1.93","article-title":"Na(+)-independent transport (uniport) of amino acids and glucose in mammalian cells","volume":"196","author":"Kakuda","year":"1994","journal-title":"J Exp Biol"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.08.001_bib70","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.FMJ04006X6","article-title":"Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase\/NO system in atherosclerosis","volume":"96","author":"Kawashima","year":"2004","journal-title":"J Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.08.001_bib71","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0026-0495(99)90127-0","article-title":"Reduced nitric oxide production by l-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation","volume":"48","author":"Kayanoki","year":"1999","journal-title":"Metabolism"},{"issue":"22","key":"10.1016\/j.pharmthera.2007.08.001_bib72","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/01.CIR.102.22.2707","article-title":"In vivo and in vitro evidence for impaired arginine transport in human heart failure","volume":"102","author":"Kaye","year":"2000","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2007.08.001_bib73","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.RES.0000047506.52381.90","article-title":"Reduced myocardial and systemic l-arginine uptake in heart failure","volume":"91","author":"Kaye","year":"2002","journal-title":"Circ Res"},{"issue":"6337","key":"10.1016\/j.pharmthera.2007.08.001_bib74","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/352725a0","article-title":"Transport of cationic amino acids by the mouse ecotropic retrovirus receptor","volume":"352","author":"Kim","year":"1991","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib76","doi-asserted-by":"crossref","first-page":"L1037","DOI":"10.1152\/ajplung.00308.2002","article-title":"Classical isoform of PKC as regulators of CAT-1 transporter activity in pulmonary artery endothelial cells","volume":"284","author":"Krotova","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2-3","key":"10.1016\/j.pharmthera.2007.08.001_bib77","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-5273(02)00413-8","article-title":"Oral l-arginine improves endothelial dysfunction in patients with essential hypertension","volume":"86","author":"Lekakis","year":"2002","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.pharmthera.2007.08.001_bib78","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.CIR.97.21.2123","article-title":"Long-term l-arginine supplementation improves small vessel coronary endothelial function in human","volume":"97","author":"Lerman","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.08.001_bib79","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1042\/bst0240846","article-title":"Regulation of cationic amino acid transporter (CAT) gene expression","volume":"24","author":"MacLeod","year":"1996","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib80","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1242\/jeb.196.1.109","article-title":"y(+)-type cationic amino acid transport: expression and regulation of the mCAT genes","volume":"196","author":"MacLeod","year":"1994","journal-title":"J Exp Biol"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1152\/physrev.00022.2002","article-title":"Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells","volume":"83","author":"Mann","year":"2003","journal-title":"Physiol Rev"},{"issue":"50","key":"10.1016\/j.pharmthera.2007.08.001_bib82","doi-asserted-by":"crossref","first-page":"31213","DOI":"10.1074\/jbc.272.50.31213","article-title":"A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the arginine paradox","volume":"272","author":"McDonald","year":"1997","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.08.001_bib83","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0008-6363(00)00267-4","article-title":"Abnormalities in l-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure","volume":"49","author":"Mendes Ribeiro","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.08.001_bib84","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","article-title":"Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase","volume":"25","author":"Munzel","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1471-4159.1996.67020645.x","article-title":"N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition","volume":"67","author":"Nguyen","year":"1996","journal-title":"J Neurochem"},{"issue":"19","key":"10.1016\/j.pharmthera.2007.08.001_bib86","doi-asserted-by":"crossref","first-page":"15881","DOI":"10.1074\/jbc.M010030200","article-title":"Sustained nitric oxide production in macrophages requires the arginine transporter CAT2","volume":"276","author":"Nicholson","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib87","doi-asserted-by":"crossref","first-page":"C136","DOI":"10.1152\/ajpcell.2000.278.1.C136","article-title":"Effects of NO donors and synthase agonists on endothelial cell uptake of l-Arg and superoxide production","volume":"278","author":"Ogonowski","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1291\/hypres.28.181","article-title":"Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension","volume":"28","author":"Okubo","year":"2005","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.08.001_bib89","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000658-199505000-00017","article-title":"TNF-stimulated arginine transport by human vascular endothelium requires activation of protein kinase C","volume":"221","author":"Pan","year":"1995","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib93","doi-asserted-by":"crossref","first-page":"H395","DOI":"10.1152\/ajpheart.01094.2003","article-title":"In vivo and in vitro evidence for ACH-stimulated l-arginine uptake","volume":"287","author":"Parnell","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.08.001_bib92","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1101\/gad.11.7.914","article-title":"Anemia and perinatal death results from loss of the murine ecotropic retrovirus receptor mCAT-1","volume":"11","author":"Perkins","year":"1997","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.08.001_bib94","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2005.04.040","article-title":"Asymmetric dimethylarginine, l-arginine, and endothelial dysfunction in essential hypertension","volume":"46","author":"Perticone","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.08.001_bib95","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0735-1097(97)00279-9","article-title":"Effect of l-arginine on human coronary endothelium-dependent and physiologic vasodilation","volume":"30","author":"Quyyumi","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib97","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/CS20010329","article-title":"Increased cationic amino acid flux through a newly expressed transporter in cells overproducing nitric oxide from patients with septic shock","volume":"102","author":"Reade","year":"2002","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"10.1016\/j.pharmthera.2007.08.001_bib98","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.CIR.93.12.2135","article-title":"Randomized, double-blind, placebo-controlled study of supplemental oral l-arginine in patients with heart failure","volume":"93","author":"Rector","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib99","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pro.5560020103","article-title":"Mammalian integral membrane receptors are homologous to facilitators and antiporters of yeast, fungi, and eubacteria","volume":"2","author":"Reizer","year":"1993","journal-title":"Protein Sci"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.08.001_bib100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0168-9525(96)10016-0","article-title":"Control of messenger RNA stability in higher eukaryotes","volume":"12","author":"Ross","year":"1996","journal-title":"Trends Genet"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.08.001_bib102","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI115132","article-title":"l-Arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits","volume":"87","author":"Rossitch","year":"1991","journal-title":"J Clin Invest"},{"issue":"3-4","key":"10.1016\/j.pharmthera.2007.08.001_bib103","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1515\/BC.2002.055","article-title":"Interactions of nitric oxide and peroxynitrite with low-density lipoprotein","volume":"383","author":"Rubbo","year":"2002","journal-title":"Biol Chem"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.08.001_bib104","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1681\/ASN.2004090735","article-title":"Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase","volume":"16","author":"Scalera","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"10.1016\/j.pharmthera.2007.08.001_bib105","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","article-title":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease","volume":"101","author":"Schachinger","year":"2000","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pharmthera.2007.08.001_bib107","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00004872-200410000-00014","article-title":"Beta-adrenoceptor-mediated, nitric oxide-dependent vasodilation is abnormal in early hypertension: restoration by l-arginine","volume":"22","author":"Schlaich","year":"2004","journal-title":"J Hypertens"},{"issue":"24","key":"10.1016\/j.pharmthera.2007.08.001_bib108","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1161\/01.CIR.0000149748.79945.52","article-title":"Impaired l-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects","volume":"110","author":"Schlaich","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib106","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.ki.5000067","article-title":"Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats","volume":"69","author":"Schwartz","year":"2006","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.08.001_bib109","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1046\/j.1432-1033.2003.03572.x","article-title":"Transport of l-arginine and nitric oxide formation in human platelets","volume":"270","author":"Signorello","year":"2003","journal-title":"Eur J Biochem"},{"issue":"5","key":"10.1016\/j.pharmthera.2007.08.001_bib110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00005344-199505000-00005","article-title":"Discordant effects of dietary l-arginine on vascular structure and reactivity in hypercholesterolemic rabbits","volume":"25","author":"Singer","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2007.08.001_bib111","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1113\/jphysiol.1995.sp021040","article-title":"Diabetes-induced activation of system y+and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization","volume":"489","author":"Sobrevia","year":"1995","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.pharmthera.2007.08.001_bib112","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/geno.1998.5252","article-title":"The gene encoding a cationic amino acid transporter (SLC7A4) maps to the region deleted in the velocardiofacial syndrome","volume":"49","author":"Sperandeo","year":"1998","journal-title":"Genomics"},{"issue":"Suppl 3","key":"10.1016\/j.pharmthera.2007.08.001_bib113","first-page":"S14","article-title":"Oxygen radical stress in vascular disease: the role of endothelial nitric oxide synthase","volume":"32","author":"Stroes","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmthera.2007.08.001_bib114","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjhyper.2004.05.005","article-title":"Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients","volume":"17","author":"Takiuchi","year":"2004","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib115","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/01.ATV.14.6.938","article-title":"l-Arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty","volume":"14","author":"Tarry","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"3","key":"10.1016\/j.pharmthera.2007.08.001_bib116","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1476-5381.1994.tb17064.x","article-title":"The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery","volume":"113","author":"Taylor","year":"1994","journal-title":"Br J Pharmacol"},{"issue":"9068","key":"10.1016\/j.pharmthera.2007.08.001_bib117","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0140-6736(05)61692-3","article-title":"Coronary stenosis dilatation induced by l-arginine","volume":"349","author":"Tousoulis","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.pharmthera.2007.08.001_bib118","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1540\/jsmr.39.249","article-title":"The endothelium in health and disease\u2014a target for therapeutic intervention","volume":"39","author":"Triggle","year":"2003","journal-title":"J Smooth Muscle Res"},{"issue":"12","key":"10.1016\/j.pharmthera.2007.08.001_bib119","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1161\/01.CIR.92.12.3513","article-title":"Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide","volume":"92","author":"Tsao","year":"1995","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pharmthera.2007.08.001_bib122","doi-asserted-by":"crossref","first-page":"12118","DOI":"10.1016\/S0021-9258(17)38994-9","article-title":"Na+-dependent of basic, zwitterionic, and bicyclic amino acids by a broad scope system in mouse blastocysts","volume":"260","author":"Van Winkle","year":"1985","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.pharmthera.2007.08.001_bib121","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1016\/S0021-9258(18)69048-9","article-title":"Na+ independent transport of basic and zwitterionic amino acids in mouse blastocysts by a shared system and by processes which distinguish between these substrates","volume":"263","author":"Van Winkle","year":"1988","journal-title":"J Biol Chem"},{"issue":"6352","key":"10.1016\/j.pharmthera.2007.08.001_bib123","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/354377a0","article-title":"Structural studies of membranes and surface layers up to 1,000 A thick using X-ray standing waves","volume":"354","author":"Wang","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2007.08.001_bib124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/bss0710121","article-title":"Clinical aspects of reactive oxygen and nitrogen species","volume":"71","author":"Warnholtz","year":"2004","journal-title":"Biochem Soc Symp"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/01.CIR.97.1.108","article-title":"Atherosclerosis and the two faces of endothelial nitric oxide synthase","volume":"97","author":"Wever","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmthera.2007.08.001_bib126","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1016\/S0021-9258(18)34742-2","article-title":"Cationic amino acid transport into cultured animal cells: I. Influx into cultured human fibroblasts","volume":"257","author":"White","year":"1982","journal-title":"J Biol Chem"},{"issue":"Pt3","key":"10.1016\/j.pharmthera.2007.08.001_bib127","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1042\/bj20020084","article-title":"Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity","volume":"364","author":"Wolf","year":"2002","journal-title":"Biochem J"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2007.08.001_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.pharmthera.2007.08.001_bib129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcm.2006.02.003","article-title":"Endothelial dysfunction and Impaired l-arginine transport in hypertension and genetically predisposed normotensive subjects","volume":"16","author":"Yang","year":"2006","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2007.08.001_bib130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ab.2003.11.006","article-title":"Simultaneous determination of arginine and seven metabolites in plasma by reverse-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization","volume":"326","author":"Zhang","year":"2004","journal-title":"Anal Biochem"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725807001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:51:48Z","timestamp":1737399108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725807001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0163725807001581"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2007.08.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}